Skip to content
akaturk Academic measurement
2025 SJR Q4 JCR Q4 · 0,5 OA 8 matched articles ESCI

Journal detail

Middle East Journal of Cancer

Publisher
Shiraz University of Medical Sciences
Country
Iran · Middle East
Type
journal
ISSN
  • 20086687
  • 20086709
Scopus 0,192 SJR
Scopus Q4 SJR Q
WoS Q4 JCR Q
WoS 0,5 JIF
Scopus 15 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,192
  • Quartile Q4
  • H-Index 15
  • Cites/doc 0,49
  • Docs (3y) 183
  • Cites (3y) 89

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q4
  • JIF 0,5
  • 5Y JIF 0,5
  • JCI 0,1

WoS indexes

  • ESCI

Subject classification

Categories (SJR)

  • Cancer Research Q4
  • Oncology Q4

Areas

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

WoS categories

  • Oncology

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q4 Q4 0,192 0,5 0,5 0,1 Q4 15
2024 Q4 Q4 0,186 0,4 0,4 0,1 Q4 12
2023 Q4 Q4 0,229 0,4 0,5 0,09 Q4 12
2022 Q4 0,172 0,4 0,5 0,06 Q4 12
2021 Q4 0,171 0,09 Q4 12
2020 Q4 0,227 0,11 Q4 12
2019 Q4 0,177 12
2017 Q4 0,139 12
2016 Q4 0,129 12
2015 Q4 0,103 12
2014 12

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 ONCOLOGY ESCI Q4 Q4 317/333
2024 ONCOLOGY ESCI Q4 Q4 313/328
2023 ONCOLOGY ESCI Q4 Q4 304/322
2022 ONCOLOGY ESCI Q4
2021 ONCOLOGY ESCI Q4
2020 ONCOLOGY ESCI Q4